FORT LAUDERDALE, FL, March 01, 2018 -- SanSal Wellness Holdings, Inc. (“SanSal Wellness” or the “Company”) (OTCQB: SSWH), a vertically-integrated agribusiness focused on producing full spectrum natural phytocannabinoid-rich industrial hemp extracts, is pleased to provide this report highlighting the Company’s extensive use of third-party laboratory testing to verify the purity and potency of every SanSal Wellness wholesale and retail industrial hemp extract product.
“Third-party laboratory testing plays a very important role in our industrial hemp extract and finished product manufacturing process,” commented Rianna Meyer, Vice President of Operations at SanSal Wellness. “Not only does a consistent program of lab testing ensure that we are constantly in compliance with state and federal legal requirements to maintain THC levels lower than 0.3%, but it also helps us monitor the health of our crop and to accurately formulate finished products with the extracted cannabinoid-rich oil. With this strict testing process in place, our customers can feel confident that every SanSal Wellness product is contaminant free and contains the precise amounts of active compounds indicated each label.”
SanSal Wellness employs third-party laboratory testing at several key stages of production, including specific tests for potency, heavy metals, residual dissolved solvents, mold, and pesticides. SanSal first employs third-party testing from when the industrial hemp plants first enter the flowering stage. During this important growth phase, the crop is regularly monitored to ensure the plants are healthy and most importantly always remain below the legal limit of 0.3% THC mandated by the Colorado Department of Agriculture. Once the crop is ready to be harvested, it is cut, hung, and dried before extraction processing.
Following the extraction process, SanSal Wellness employs third-party laboratory tests on the “first-cut” oil extract. This cannabinoid potency testing once again confirms the required <0.3% THC and enables product formulators to accurately create the SanSal Wellness finished products like cannabinoid-rich tinctures, salves, lotions, etc. Additional third-party tests are conducted after each batch of finished products is completed.
Rianna Meyer concluded, “It’s very apparent that many hemp extract products on the market today don’t contain what they claim to and could never live up to the expectations of an informed consumer. One of the more important jobs that we have is to help educate the consumer that not all hemp extract products are created equal. By extensively using third-party lab testing to verify potency and purity at three distinct stages of production (flowering, extraction, and formulation), SanSal Wellness can produce the highest quality industrial hemp extract products and make consumers and wholesale buyers feel confident about what they are taking for themselves or recommending to friends and family.”
For additional information, visit www.sansalwellness.com.
About SanSal Wellness Holdings, Inc.
SanSal Wellness Holdings, Inc. (OTCQB: SSWH) is focused on producing superior quality, whole-plant, broad spectrum phytocannabinoid-rich hemp oils and extracts. SanSal Wellness currently operates a 140-acre farm and production facilities in Pueblo, Colorado, and is registered with the Colorado Department of Agriculture to grow industrial hemp. The Company files periodic reports with the Securities and Exchange Commission, which can be viewed at www.sec.gov.
Cautionary Language Concerning Forward-Looking Statements
This SanSal Wellness Holdings, Inc. press release contains “forward-looking statements” within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. All statements, other than statements of historical fact, including those with respect to the Company’s mission statement and growth strategy, are “forward-looking statements.” Although the Company's management believes that such forward-looking statements are reasonable, it cannot guarantee that such expectations are, or will be, correct. These forward-looking statements involve many risks and uncertainties, which could cause the Company’s future results to differ materially from those anticipated. Potential risks and uncertainties include, among others, general economic conditions and conditions affecting the industries in which the Company operates; the uncertainty of regulatory requirements and approvals; and the ability to obtain necessary financing on acceptable terms or at all. Additional information regarding the factors that may cause actual results to differ materially from these forward-looking statements is available in the Company’s filings with the Securities and Exchange Commission. The Company assumes no obligation to update any of the information contained or referenced in this press release.
SanSal Wellness Holdings, Inc. - IR/Media Contact Toll-Free: (888) 549-7888 E-mail: [email protected]


Mercedes-Benz Stock Offers Deep-Value Potential as Citi Sees Recovery Catalysts
Alphabet Stock Slides as Google AI Pioneer Jeff Dean Exits to Launch Discovery Loop
Delta Flight Makes Emergency Landing in Atlanta After Cockpit Fumes Reported
OpenAI Restricts Astra AI Over Cyberattack Risks
Berkshire Hathaway Cash Falls as Abel Boosts Stock Buybacks
Heineken H1 Operating Profit Meets Forecast as Beer Volumes Beat Expectations
DoorDash Q2 Revenue Jumps 36% as Orders and DashPass Growth Drive Results
Nvidia to Invest Up to $3 Billion in Blackstone-Backed Lancium
DeepSeek to Raise AI API Prices as Demand for New Models Surges
SanDisk Q4 Earnings Beat Estimates as Q1 Revenue Outlook Meets Expectations
Sinopec Boosts Russian ESPO Oil Purchases as Middle East Supply Tightens
Novo Nordisk Raises 2025 Outlook Despite Wegovy Pill Miss and CagriSema Setback
UOB Q2 Net Profit Rises 10% as Wealth Management Growth Boosts Earnings
Western Digital Q4 Earnings Beat Estimates as FY2027 Outlook Tops Expectations
Siemens Energy Q3 Profit Beats Forecast as AI-Driven Power Demand Fuels Growth
Meta AI Model Exploits Security Flaw During Cybersecurity Test, Raising AI Safety Concerns
Daimler Truck Q2 Profit Falls 18%, 2026 Outlook Raised 



